Session 6: Advances for Immunotherapy in Prostate Cancer
12:20 PM – 1:15 PM
Moderator:
Howard Soule, PhD
Prostate Cancer Foundation
Introduction
Howard Soule, PhD
Prostate Cancer Foundation
Clinical Development of PSCA-Targeted CAR T Cells for Advanced Prostate Cancer
Tanya Dorff, MD
City of Hope
Co-expression of a Novel TGFβR Dominant Negative Receptor to Enhance PSMA Chimeric Antigen Receptor Therapy in the Treatment of Castrate Resistant Prostate Cancer Patients
Naomi Haas, MD
University of Pennsylvania